Literature DB >> 24640936

Ion mobility derived collision cross sections to support metabolomics applications.

Giuseppe Paglia1, Jonathan P Williams, Lochana Menikarachchi, J Will Thompson, Richard Tyldesley-Worster, Skarphédinn Halldórsson, Ottar Rolfsson, Arthur Moseley, David Grant, James Langridge, Bernhard O Palsson, Giuseppe Astarita.   

Abstract

Metabolomics is a rapidly evolving analytical approach in life and health sciences. The structural elucidation of the metabolites of interest remains a major analytical challenge in the metabolomics workflow. Here, we investigate the use of ion mobility as a tool to aid metabolite identification. Ion mobility allows for the measurement of the rotationally averaged collision cross-section (CCS), which gives information about the ionic shape of a molecule in the gas phase. We measured the CCSs of 125 common metabolites using traveling-wave ion mobility-mass spectrometry (TW-IM-MS). CCS measurements were highly reproducible on instruments located in three independent laboratories (RSD < 5% for 99%). We also determined the reproducibility of CCS measurements in various biological matrixes including urine, plasma, platelets, and red blood cells using ultra performance liquid chromatography (UPLC) coupled with TW-IM-MS. The mean RSD was < 2% for 97% of the CCS values, compared to 80% of retention times. Finally, as proof of concept, we used UPLC-TW-IM-MS to compare the cellular metabolome of epithelial and mesenchymal cells, an in vitro model used to study cancer development. Experimentally determined and computationally derived CCS values were used as orthogonal analytical parameters in combination with retention time and accurate mass information to confirm the identity of key metabolites potentially involved in cancer. Thus, our results indicate that adding CCS data to searchable databases and to routine metabolomics workflows will increase the identification confidence compared to traditional analytical approaches.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24640936      PMCID: PMC4004193          DOI: 10.1021/ac500405x

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


Metabolomics, a powerful analytical strategy in translational medicine and biomarker discovery, relies on advanced technology to profile metabolites in cells, tissues, and biofluids.[1−3] The confident identification of these metabolites on a high-throughput scale, however, remains a major analytical challenge because of their chemical and structural diversity. Thus, implementing workflows that involve orthogonal analytical tools might facilitate metabolite identification.[4] Mass spectrometry (MS) is a widely used technique for analyzing small molecules.[5] Because of the complexity of the metabolome, MS-based metabolomics analyses are usually performed in conjunction with liquid chromatography (LC).[5] Analyzing hydrophilic compounds by means of traditional reversed-phase LC–MS is not ideal as these metabolites are poorly retained and usually elute in the void volume.[6,7] On the other hand, it has been demonstrated that hydrophilic interaction liquid chromatography–MS (HILIC–MS) improves resolution, identification, and quantification for these types of compounds.[7−10] Intersample variability caused by using different matrixes and sample loading, however, can lead to shifts in retention times, which complicates the use of retention time for identification purposes. The coupling of UPLC with ion mobility MS (UPLC–IM-MS) is a promising analytical technique within the field of metabolomics.[11−16] Ion mobility spectrometry is a gas-phase electrophoretic technique that separates ions according to their charge, shape, and size. Ion separation occurs in the millisecond time frame, making it compatible with time-of-flight mass spectrometry. The CCS[17] for a given ion can be derived by measuring the time required for an ion to traverse a chamber filled with an inert gas. The CCS value is a unique physicochemical property of a molecule. Using CCS as an orthogonal molecular descriptor in addition to retention time and mass-to-charge ratio (m/z) offers the opportunity to further improve the identification process, making it more robust and reproducible across multiple samples and timeframes.[13−16,18−23] Such an approach remains largely unexplored in metabolomics applications. During this study, we incorporated ion mobility into the UPLC–MS, metabolomics workflow. We generated a CCS database of common cellular metabolites, validated across multiple laboratories, which was ultimately used to confidently identify the metabolic alterations related to the epithelial–mesenchymal transition process. Our study highlights the benefit of using ion mobility in metabolomics

Experimental Section

Chemicals

All materials were obtained from Sigma-Aldrich (Germany) unless stated otherwise. Acetonitrile (ACN) was purchased from Merck KGaA, (Darmstadt, Germany). Water was obtained using an 18 Ω m Milli-Q (EMD Millipore Corporation, Billerica, MA). All chemicals and solvents were of analytical grade or higher purity. Poly-dl-alanine (product number P9003) was purchased from Sigma-Aldrich (U.K.). Platelets (PLT), red blood cells (RBC), and plasma were obtained from the Blood Bank, Landspitali-University Hospital, Reykjavik, Iceland). Urine was obtained from a male volunteer. This study was approved by the National Bioethics Committee of Iceland and the Icelandic Data Protection Authority.

Sample Preparation

Standard Mixtures

Mixtures containing between 10 and 15 standard metabolites (each with a different molecular weight) were prepared in H2O/ACN (50:50, v:v), at a concentration of 10 mg/L.

Biological Samples

A volume of 0.5 mL of PLT and RBC concentrates were used to extract intracellular metabolites using methanol (MeOH)/H2O (7:3, v:v), as previously described.[7] The supernatant was dried and reconstituted in 0.3 mL of H2O/ACN (50:50, v:v). Plasma samples (0.3 mL) were processed by adding 0.9 mL of MeOH. After centrifugation (10 min, 4 °C, 10 000g), the supernatant was dried and reconstituted in 0.15 mL of H2O/ACN (50:50, v:v). Urine samples (0.2 mL) were processed adding 0.6 mL of MeOH. After centrifugation (10 min, 4 °C, 10 000g), the supernatant was dried and reconstituted in 0.5 mL of H2O/ACN (50:50, v:v).

Cell Culture

D492 breast epithelial cells and D492M, epithelially derived mesenchymal cells were cultured as previously described.[24] Briefly, cells were cultured to confluency in H14 medium at 37 °C and 5% CO2. After 3 days in culture, the cells were trypsinized, collected by centrifugation, counted, and washed three times with PBS. Intracellular metabolites were extracted using MeOH/H2O (7:3 v:v) as previously described.[7]

MS Analysis

Three traveling-wave ion mobility mass spectrometers (TW-IM-MS)[25] (Synapt G2 HDMS, Waters Corporation, Manchester, U.K.) located in independent laboratories were used to derive CCS information for a variety of small low molecular weight, polar metabolites (Table S1 in the Supporting Information). The first Synapt HDMS system was located in Durham, NC. In positive electrospray mode, the capillary and cone voltage were 2.6 kV and 35 V, respectively. The source and desolvation temperatures were 100 and 150 °C, respectively, and the desolvation gas flow was 600 L/h. Nitrogen, the IMS gas, flowed at a rate of 90 mL/min (3.2 mbar), with a wave velocity of 600 m/s and wave height of 40 V. In negative electrospray mode, the capillary and cone voltage were 2.3 kV and 25 V, respectively. The source and desolvation temperature were 100 and 150 °C, respectively, and the desolvation gas flow was 600 L/h. Nitrogen, the IMS gas, flowed at a rate of 90 mL/min (3.2 mbar), with a wave velocity of 650 m/s and wave height of 40 V. The EDC delay coefficient was specified as 1.36 V in positive mode and as 1.41 in negative mode. In both positive and negative mode, direct injection at a flow rate of 0.75 μL/min was used. The second Synapt HDMS system was located in Manchester, U.K. In positive electrospray mode, the capillary and cone voltage were 2.5 kV and 30 V, respectively. The source and desolvation temperature were 100 and 250 °C, respectively, and the desolvation gas flow was 600 L/h. Nitrogen, the IMS gas, flowed at a rate of 90 mL/min (3.2 mbar), with a wave velocity of 750 m/s and wave height of 40 V. In negative electrospray mode, the capillary and cone voltage were 2 kV and 40 V, respectively. The source and desolvation temperature were 100 and 250 °C, respectively, and the desolvation gas flow was 600 L/h. Nitrogen, the IMS gas, flowed at a rate of 90 mL/min (3.2 mbar), with a wave velocity of 800 m/s and wave height of 40 V. The EDC delay coefficient was specified as 1.58 V. Direct injection at a flow rate of 5 μL/min was used in both positive and negative mode. The third Synapt HDMS system was located in Reykjavik, Iceland. In positive electrospray mode, the capillary and cone voltage were 1.5 kV and 30 V, respectively. The source and desolvation temperature were 120 and 500 °C, respectively, and the desolvation gas flow was 800 L/h. Nitrogen, the IMS gas, flowed at a rate of 90 mL/min (3.2 mbar), with a wave velocity of 600 m/s and wave height of 32 V. In negative electrospray mode, the capillary and cone voltage were 1.5 kV and 30 V, respectively. The source and desolvation temperature were 120 and 500 °C, respectively, and the desolvation gas flow was 800 L/h. Nitrogen, the IMS gas, flowed at a rate of 90 mL/min (3.2 mbar), with a wave velocity of 600 m/s and wave height of 32 V. The EDC delay coefficient was specified as 1.58 V. Argon served as collision gas in both positive and negative mode. During HDMSE experiments, the collision energy in the trap cell was 4 eV (Function 1), and in the transfer cell, it ranged from 20 to 30 eV (Function 2). In both positive and negative mode, direct injection, at a flow rate of 0.75 μL/min, or UPLC was used.

Liquid Chromatographic Analysis

Chromatographic separation was achieved using an ACQUITY UPLC system (UPLC ACQUITY, Waters Corporation, Milford, MA) and hydrophilic-interaction liquid chromatography (HILIC) using a 1.7-μm (2.1 mm × 150 mm) ACQUITY amide column (Waters Corporation). Samples and standard mixtures were analyzed three times in UPLC–HILIC-HDMSE, once in positive ionization mode and twice in negative ionization mode using acidic and basic chromatographic conditions, respectively. In positive mode and in negative acidic conditions alike, mobile phase A was 100% ACN and mobile phase B was 100% H2O, with both containing 0.1% formic acid. The following elution gradient was used: 0 min, 99% A; 6 min, 40% A; 8 min, 99% A; 10 min, 99% A. In negative-mode basic conditions, mobile phase A contained ACN/sodium bicarbonate, 10 mM (95:5) and mobile phase B contained ACN/sodium bicarbonate, 10 mM (5:95). The following elution gradient was used: 0 min, 99% A; 5 min, 42% A; 6 min, 70% A; 7 min, 99%; 10 min, 99% A. In all conditions, the flow rate was 0.4 mL/min, the column temperature 45 °C, and the injection volume 3.5 μL.

CCS Measurements for Metabolites

CCS values obtained in nitrogen were experimentally determined using previously published CCS values for singly charged polyalanine oligomers as the TW mobility calibrant[26,27] (Table S2, Supporting Information). Experimental procedures for measuring CCS are outlined in Figure S1 (see the Supporting Information for more details). Poly-dl-alanine was used as the calibrant species in both electrospray positive (ES+) and ES– and was prepared in H2O/ACN (50:50, v:v) at a concentration of 10 mg/L. Calibration was performed using oligomers from n = 3 to n = 11, covering a mass range from 231 to 799 Da and a CCS range from 151 Å2 to 306 Å2 in ES+ and from 150 Å2 to 308 Å2 in ES– (Table S2, Supporting Information).[26] CCSs were derived using a procedure previously reported.[26] The ion mobility resolution was ∼40 (fwhm). The ion mobility peak or arrival time distribution (ATD) may represent a combination of structurally similar isomers that remain unresolved. The CCS values reported were determined at the apex of the ion mobility peak or ATD. The use of different ionization sources (causing different interferences that are not resolved) and/or different mobility calibrants could lead to slight variations in the reported CCS.[28]

Prediction of CCS via Computational Methods

Theoretical collisional cross sections were calculated as follows. First, two- dimensional (2D) structures for the compounds were downloaded from NCBI’s PubChem database[29] in SD file format. Following this, ChemAxon’s (ChemAxon, 5.4.1.1.) pKa module was used to calculate the most acidic or most basic atom in each 2D structure. Protonated and sodiated forms were generated by connecting a hydrogen or a sodium atom to the most basic atom in the 2D structure. The formal charge of the most basic atom was then set to +1. Similarly, a hydrogen attached to the most acidic atom was disconnected to generate deprotonated structures. Then, ChemAxon’s conformer plugin was used to generate molecular mechanics (using MMFF94 force field) based lowest energy conformers. Each molecular mechanics based minimum energy conformer was reoptimized with the density functional theory B3LYP/6-31g*. Density functional calculations were done with Gaussian09.[30] All structure manipulations (generation of ionized forms and molecular mechanics based conformers) and input file preparations (for Gaussian09 and Mobcal) were done using MolFind’s tools panel.[31] Finally, a modified version of Mobcal[32−34] optimized according to the room temperature N2-based trajectory method (TM) was used for calculating average collision cross-sectional areas.

Data Processing and Analysis

Progenesis QI v1.0 (Nonlinear Dynamics, Newcastle, U.K.) was used for visualization, processing, and interpretation of multidimensional IM-MS data. Each UPLC–IM-MS run was imported as an ion intensity map, including m/z and retention time. These ion maps were then aligned in the retention time direction. From the aligned runs, Progenesis QI produces an aggregate run that was representative of the compounds in all samples and used this aggregate run for peak picking. The peak picking from this aggregate was then propagated to all runs, so that the same ions are detected in every run. Isotope and adduct deconvolution was applied to reduce the number of features detected. Data were normalized using total ion intensity. The software was coded to directly convert drift time data into CCS values using the polyalanine calibration curve. Statistically significant alterations were identified using multivariate statistics, including principal components analysis (PCA) and orthogonal partial least square-discriminant analysis (OPLS-DA) and further confirmed using analysis of variance (ANOVA). Metabolites were identified by searching in the Human Metabolome Database (HMDB),[35] METLIN,[36,37] and in-house databases with Δppm < 10, retention time range < 0.3 s, and ΔCCS < 5 Å2 as tolerance parameters. Fragment ion mass spectra were analyzed in both MSE and HDMSE mode.

Results and Discussion

Investigating the use of ion mobility to support metabolomic applications, we conducted a multilaboratory study to obtain the CCS values of 125 standard metabolites, using both experimentally derived and computationally calculated approaches. This data was used to create a unique database, which contained not only retention time and m/z information, but also CCS values for each structure. In order to validate the database and its unique capabilities, we conducted metabolomics analyses of biological samples using the additional CCS information to aid in the identification of metabolites.

Experimentally- and Computationally Derived CCSs of Common Metabolites

Experimental procedures for measuring CCSs are based on calibration with compounds having known CCS values as reported in the Experimental Section (Figure S1, Supporting Information). In order to represent the chemical complexity of the cellular metabolome, we selected as unknowns 125 metabolites representing key metabolic pathways. These metabolites included sugars, phosphorylated compounds, purines and pyrimidines, nucleotides, nucleosides, acylcarnitines, carboxylic acids, hydrophilic vitamins and amino acids (Figure 1 and Table S3 in the Supporting Information). We measured drift times in nitrogen for these metabolites using TW-IM-MS instruments located in three independent laboratories (Table S4, Supporting Information). We then derived CCS values using polyalanine oligomers as mobility calibrants in both positive and negative ES mode of operation. The polyalanine standards allowed us to correct for variation in drift times between instruments located in different laboratories and having different ion mobility parameter settings (Figure 2a). We derived 209 CCS values (96 in positive and 113 in negative ion mode) with an interlaboratory RSD% lower than 5% for 99% of the measurements (Figure 2b). These results support the proposition that a CCS value derived from calibration is an absolute measurement, representing a physicochemical property that is consistent across a range of experimental and instrumental conditions. Experimentally derived CCS values highlighted trend lines related to different chemical classes (Figure 1c). Furthermore, experimentally derived CCS values correlated closely with theoretical CCS calculated using Mobcal (Figure 1d and Table S4, Supporting Information).
Figure 1

CCS measurements for 125 common metabolites: (a) visual representation of the metabolites analyzed in this study (red dots) according to their metabolic position in a KEGG metabolic map. (b) Classes of cellular metabolites included in this study. (c) Correlation between CCS and mass values. Both CCS value in negative and positive modes were used, and sodium adducts were excluded except for sugars: amino acids and derivatives (n = 55, R = 0.91); carboxylic acids (n = 9, R = 0.90); nucleobases (n = 16, R = 0.88); phosphorylated compounds (n = 15, R = 0.84); sugar (n = 13, R = 0.99); sugar sodium adducts (n = 12, R = 0.99); nucleosides (n = 19, R = 0.94); nucleotides (n = 23, R = 0.81). (d) Correlation between experimentally derived and computationally predicted CCS values.

Figure 2

Reproducibility of CCS measurements across different instruments: (a) different drift time values for reduced glutathione were obtained using different TW-IM parameter settings. The use of polyalanine as calibrators corrected the final CCSs measurements. (b) Relative standard deviation (RSD%) for CCS measurements across three independent laboratories.

CCS measurements for 125 common metabolites: (a) visual representation of the metabolites analyzed in this study (red dots) according to their metabolic position in a KEGG metabolic map. (b) Classes of cellular metabolites included in this study. (c) Correlation between CCS and mass values. Both CCS value in negative and positive modes were used, and sodium adducts were excluded except for sugars: amino acids and derivatives (n = 55, R = 0.91); carboxylic acids (n = 9, R = 0.90); nucleobases (n = 16, R = 0.88); phosphorylated compounds (n = 15, R = 0.84); sugar (n = 13, R = 0.99); sugar sodium adducts (n = 12, R = 0.99); nucleosides (n = 19, R = 0.94); nucleotides (n = 23, R = 0.81). (d) Correlation between experimentally derived and computationally predicted CCS values. Reproducibility of CCS measurements across different instruments: (a) different drift time values for reduced glutathione were obtained using different TW-IM parameter settings. The use of polyalanine as calibrators corrected the final CCSs measurements. (b) Relative standard deviation (RSD%) for CCS measurements across three independent laboratories.

Generation of a Database Containing Retention Time, CCS, and m/z Values

To allow a more comprehensive LC separation of the different classes of compounds used in this study, we coupled UPLC with TW-IM-MS. Notably, the analysis of polar metabolites using traditional reversed-phase LC–MS presents some challenges because they are poorly retained and usually eluted in the void volume.[6−10] Two different HILIC methods (i.e., acidic and basic) were used (for details see the Experimental Section). Basic conditions were chosen to separate phosphorylated compounds, such as nucleotides and sugar phosphates, which under acidic conditions were strongly retained, resulting in poor chromatographic peak shape.[7,8] Using HILIC conditions, our set of polar metabolites eluted in order of increasing polarity (Table S3, Supporting Information). For each of the 125 compounds included in this study, we annotated values for accurate mass, CCS, and retention time, creating a database that was then used to analyze biological samples.

Application of Ion Mobility-Derived Information to the Analysis of Biological Samples

To evaluate the applicability of this approach to metabolomic applications, we analyzed plasma, urine, red blood cells (RBCs), and platelets (PLTs) using UPLC–TW-IM-MS. In these experiments, we calculated the ΔCCS (the difference between the database CCS and the experimental CCS) and used this as a contribution to the identification score in addition to retention time and accurate mass. This enabled us to search for metabolites whose identifications have a CCS error less than a given threshold. Thus, we were able to filter and score identifications when querying our database with CCS information. Using CCS, retention time, and accurate mass as orthogonal coordinates, a total of 94 different metabolites were confirmed to be present in the various biological matrixes (48 in plasma, 46 in urine, 74 in RBCs, and 71 in PLTs). The retention time of a given metabolite can change from one run to the next due to experimental drift (e.g., room/column temperature and degradation of the column). Moreover, different sample matrixes can influence the reproducibility of retention times, largely due to different salt and lipid contents. Figure 3a shows the extracted-ion chromatogram of arginine in different matrixes, highlighting the effect of the matrix on retention time. In Figure 3b, we present the extracted-ion chromatogram resulting from the ion mobility separation showing the absence of the matrix effect on drift time. Our results showed a RSD% <2 for 97% of the CCS measurements, compared with 80% for the retention time values, suggesting that CCS measurements are more stable and reliable than retention time and thus may add more confidence in the identification process during metabolomics experiments (Figure 3c,d).
Figure 3

Matrix effect on retention times compared to CCSs: (a) extracted-ion chromatograms and (b) extracted-ion mobility chromatograms of arginine analyzed in four different biological matrixes (plasma, red blood cells, platelets, and urine). (c) Retention times reproducibility and (d) CCSs reproducibility in the various biological matrixes.

Matrix effect on retention times compared to CCSs: (a) extracted-ion chromatograms and (b) extracted-ion mobility chromatograms of arginine analyzed in four different biological matrixes (plasma, red blood cells, platelets, and urine). (c) Retention times reproducibility and (d) CCSs reproducibility in the various biological matrixes. To confirm the identity of the metabolites, we performed the analysis using data-independent or UPLC–“MSE” mode of acquisition, which alternates between a low and elevated collision energy regime. At low collision energy, the exact mass measurements of unfragmented precursor ions are obtained, whereas at the elevated collision energy, the product ions for all precursors are obtained.[38,39] In biological samples, however, multiple analytes often have indistinguishable retention times. Consequently, applying elevated collision energy in MSE mode might lead to the generation of product ions derived from multiple precursor ions at a given retention time, complicating the identification process (Figure S2, Supporting Information). To overcome this problem, we used a combination of MSE and ion mobility, HDMSE, which allows the drift time separation of coeluting precursor metabolites before the fragmentation process takes place. Precursor ions and fragment ions were ion mobility-aligned to filter out fragments that do not match the precursor’s drift time. Precursor separation was important for obtaining a cleaner collision-induced dissociation spectrum that is not contaminated from a mixture of coeluting compounds. The use of ion mobility thus provided a simplified and cleaned product ion spectrum that facilitated the identification process (Figure S2, Supporting Information). HDMSE ultimately resulted in a better performance in terms of converting feature detected in metabolites identified, increasing the ratio feature/metabolites compared to a typical LC–MS.[40] Such results are in agreement with previous studies showing that HDMSE provides better clarity and depth of coverage for the analysis of complex samples compared to regular MS approaches.[41−43] In an in depth analysis of the precision and accuracy of HDMSE, it has been shown that with ion mobility activated, the number of ion detections and accurate-mass retention-time pairs increased at an average rate of 24.4 and 26.6%, respectively, while at the same time, the average number of ion interference events dropped from 20.2 to 5.4%.[41−43]

Application of Ion Mobility-Derived Information to Metabolomics

We applied the approach described above to investigate the metabolic alterations occurring during the epithelial–mesenchymal transition process. Such a process occurs during embryonic development whereby epithelial cells acquire mesenchymal, fibroblast-like properties and display reduced intracellular adhesion and increased motility. It is also the means by which malignant epithelial tumors metastasize.[24,44,45] This tightly regulated process is associated with a number of cellular and molecular events, many of which are not yet characterized. In order to shed light on the metabolic events leading to the differentiation of epithelial and mesenchymal cells, we compared the metabolome of D492 breast epithelial cells (n = 4) with that of D492 M epithelially derived mesenchymal cells (n = 4) using HILIC UPLC–TW-IM-MS. Data processing and analysis highlighted three molecular features as major contributors to the variance between epithelial and mesenchymal cells (Figure 4 and Figure S3, Supporting Information). The accurate-mass measurements of these discriminating features were searched against HMDB and METLIN and resulted in a list of potential identifications based on accurate-mass error (<5 ppm). Review of such a list was supported by the use of HDMSE fragmentation spectra, retention time, and isotopic pattern deviation (Figure 4). Drift time data of unknown species were directly converted to CCS values by calibrating with polyalanine ions of known CCS, providing an additional coordinate for metabolite characterization (Figure 4 and Figure S3, Supporting Information). Comparing the experimental CCS values with those reported in our database, we were able to confirm the identity of inosine and guanosine as two of the features of interest (ΔCCS = 0.1% Å2 for inosine and ΔCCS = 0.4% Å2 for guanosine) (Figure 4). The third molecular feature at m/z 135.0309 was identified as a hypoxanthine-like fragment derived from in-source breakdown of inosine (Figure 4). These results indicate that CCS can be used as an orthogonal analytical parameter alongside the traditional molecular identifiers of precursor accurate mass, fragment ion accurate mass, isotope pattern, and chromatographic retention time as a confirmation of metabolite identity to increase the confidence of identification.[46]
Figure 4

Experimentally determined CCS information in support of metabolite identification. Retention times, m/z, CCS, isotopic pattern, and fragmentation information were used to identify metabolites that had a statistically significant alteration during the epithelial–mesenchymal transition process: (a) overlaid, extracted-ion chromatograms of inosine and guanosine in epithelial and mesenchymal cells. (b) Low- and high-energy spectra for inosine in HDMSE mode. (c) Low- and high-energy spectra for guanosine in HDMSE mode. Data processing and analysis performed using Progenesis QI v1.0.

Experimentally determined CCS information in support of metabolite identification. Retention times, m/z, CCS, isotopic pattern, and fragmentation information were used to identify metabolites that had a statistically significant alteration during the epithelial–mesenchymal transition process: (a) overlaid, extracted-ion chromatograms of inosine and guanosine in epithelial and mesenchymal cells. (b) Low- and high-energy spectra for inosine in HDMSE mode. (c) Low- and high-energy spectra for guanosine in HDMSE mode. Data processing and analysis performed using Progenesis QI v1.0. An obvious limitation of this approach is that it is impractical to prepare a completely comprehensive database containing experimental CCS’s for all compounds present across metabolomes. An alternative strategy that would potentially alleviate this problem is the use of computationally predicted CCSs.[31] In cases where mass measurements and Δppm are not able to differentiate between potential candidate metabolites obtained from a database search, a comparison between the experimental and theoretical CCS values can support the identification process. As an example, the accurate m/z at 267.0728 for inosine was searched against the HMDB and METLIN database leading to four potential candidates, with Δppm < 5 ppm (Table 1). Three out of the four matches had identical Δppm values but different CCS values. In such a case, ΔtCCS (the difference between the theoretical CCS and the experimental CCS) was used to filter the potential candidates, increasing the confidence of identification for inosine (the compound with the lowest ΔtCCS, Table 1). These results indicate that computationally predicted CCS might be used as an indicator of compound structure to aid metabolite identification during searches in large metabolite database, potentially reducing the number of false positive and false negative identifications.
Table 1

List of Potential Metabolite Candidates for m/z 267.0728 after a Search in the HMDB Database with a Cutoff of 5 ppma

Theoretical CCS values were compared with the experimental CCS value for inosine to generate ΔtCCS in support of mass measurement to aid metabolite identification. Three-dimensional structures of energy-minimized metabolites showing the different conformations after molecular modeling.

Theoretical CCS values were compared with the experimental CCS value for inosine to generate ΔtCCS in support of mass measurement to aid metabolite identification. Three-dimensional structures of energy-minimized metabolites showing the different conformations after molecular modeling.

Conclusions

In this study, we integrated ion mobility into a typical LC–MS-based workflow for routine metabolomics applications. The use of ion mobility in combination with UPLC–MS and UPLC–MS/MS increased the system peak capacity and specificity for metabolite identification. Ion mobility was used to measure CCS values for 125 metabolites across three independent laboratories, demonstrating high intra- and interlaboratory reproducibility. The creation of a searchable database for metabolites that includes CCS as an orthogonal analytical measurement, in addition to retention time and m/z, increased the confidence of metabolite identification compared to traditional LC–MS approaches. Metabolomics applications using direct infusion or desorption ionization sources in combination with TW-IM-MS could particularly benefit from the use of CCS-containing databases to support metabolite identification.[20,47−49] We encourage further studies to extend and populate existing metabolite databases with CCS values for metabolomics and other small molecules applications.
  42 in total

1.  Structural characterization of drug-like compounds by ion mobility mass spectrometry: comparison of theoretical and experimentally derived nitrogen collision cross sections.

Authors:  Iain Campuzano; Matthew F Bush; Carol V Robinson; Claire Beaumont; Keith Richardson; Hyungjun Kim; Hugh I Kim
Journal:  Anal Chem       Date:  2011-12-27       Impact factor: 6.986

Review 2.  Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy.

Authors:  Warwick B Dunn; David I Broadhurst; Helen J Atherton; Royston Goodacre; Julian L Griffin
Journal:  Chem Soc Rev       Date:  2010-08-17       Impact factor: 54.564

3.  Global metabolic profiling procedures for urine using UPLC-MS.

Authors:  Elizabeth J Want; Ian D Wilson; Helen Gika; Georgios Theodoridis; Robert S Plumb; John Shockcor; Elaine Holmes; Jeremy K Nicholson
Journal:  Nat Protoc       Date:  2010-06       Impact factor: 13.491

Review 4.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 5.  Ion mobility-mass spectrometry.

Authors:  Abu B Kanu; Prabha Dwivedi; Maggie Tam; Laura Matz; Herbert H Hill
Journal:  J Mass Spectrom       Date:  2008-01       Impact factor: 1.982

6.  Comprehensive LC-MS E lipidomic analysis using a shotgun approach and its application to biomarker detection and identification in osteoarthritis patients.

Authors:  Jose M Castro-Perez; Jurre Kamphorst; Jeroen DeGroot; Floris Lafeber; Jeff Goshawk; Kate Yu; John P Shockcor; Rob J Vreeken; Thomas Hankemeier
Journal:  J Proteome Res       Date:  2010-05-07       Impact factor: 4.466

Review 7.  A practical guide to metabolomic profiling as a discovery tool for human heart disease.

Authors:  Lisa C Heather; Xinzhu Wang; James A West; Julian L Griffin
Journal:  J Mol Cell Cardiol       Date:  2012-12-08       Impact factor: 5.000

8.  Characterizing ion mobility-mass spectrometry conformation space for the analysis of complex biological samples.

Authors:  Larissa S Fenn; Michal Kliman; Ablatt Mahsut; Sophie R Zhao; John A McLean
Journal:  Anal Bioanal Chem       Date:  2009-02-27       Impact factor: 4.142

9.  Endothelial induced EMT in breast epithelial cells with stem cell properties.

Authors:  Valgardur Sigurdsson; Bylgja Hilmarsdottir; Hekla Sigmundsdottir; Agla J R Fridriksdottir; Markus Ringnér; Rene Villadsen; Ake Borg; Bjarni A Agnarsson; Ole William Petersen; Magnus K Magnusson; Thorarinn Gudjonsson
Journal:  PLoS One       Date:  2011-09-06       Impact factor: 3.240

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  65 in total

Review 1.  New mass spectrometry technologies contributing towards comprehensive and high throughput omics analyses of single cells.

Authors:  Sneha P Couvillion; Ying Zhu; Gabe Nagy; Joshua N Adkins; Charles Ansong; Ryan S Renslow; Paul D Piehowski; Yehia M Ibrahim; Ryan T Kelly; Thomas O Metz
Journal:  Analyst       Date:  2019-01-28       Impact factor: 4.616

2.  Predicting Ion Mobility Collision Cross-Sections Using a Deep Neural Network: DeepCCS.

Authors:  Pier-Luc Plante; Élina Francovic-Fontaine; Jody C May; John A McLean; Erin S Baker; François Laviolette; Mario Marchand; Jacques Corbeil
Journal:  Anal Chem       Date:  2019-04-01       Impact factor: 6.986

3.  Characterization of the Impact of Drug Metabolism on the Gas-Phase Structures of Drugs Using Ion Mobility-Mass Spectrometry.

Authors:  Dylan H Ross; Ryan P Seguin; Libin Xu
Journal:  Anal Chem       Date:  2019-10-29       Impact factor: 6.986

4.  New Frontiers in Lipidomics Analyses using Structurally Selective Ion Mobility-Mass Spectrometry.

Authors:  Rachel A Harris; Katrina L Leaptrot; Jody C May; John A McLean
Journal:  Trends Analyt Chem       Date:  2019-04-06       Impact factor: 12.296

5.  Enhancing bottom-up and top-down proteomic measurements with ion mobility separations.

Authors:  Erin Shammel Baker; Kristin E Burnum-Johnson; Yehia M Ibrahim; Daniel J Orton; Matthew E Monroe; Ryan T Kelly; Ronald J Moore; Xing Zhang; Roger Théberge; Catherine E Costello; Richard D Smith
Journal:  Proteomics       Date:  2015-07-03       Impact factor: 3.984

6.  Ion Mobility Spectrometry-Mass Spectrometry Coupled with Gas-Phase Hydrogen/Deuterium Exchange for Metabolomics Analyses.

Authors:  Hossein Maleki; Ahmad K Karanji; Sandra Majuta; Megan M Maurer; Stephen J Valentine
Journal:  J Am Soc Mass Spectrom       Date:  2017-09-27       Impact factor: 3.109

7.  ISiCLE: A Quantum Chemistry Pipeline for Establishing in Silico Collision Cross Section Libraries.

Authors:  Sean M Colby; Dennis G Thomas; Jamie R Nuñez; Douglas J Baxter; Kurt R Glaesemann; Joseph M Brown; Meg A Pirrung; Niranjan Govind; Justin G Teeguarden; Thomas O Metz; Ryan S Renslow
Journal:  Anal Chem       Date:  2019-03-06       Impact factor: 6.986

8.  Juice Index: an integrated Sauvignon blanc grape and wine metabolomics database shows mainly seasonal differences.

Authors:  Farhana R Pinu; Sergey Tumanov; Claire Grose; Victoria Raw; Abby Albright; Lily Stuart; Silas G Villas-Boas; Damian Martin; Roger Harker; Marc Greven
Journal:  Metabolomics       Date:  2019-01-02       Impact factor: 4.290

9.  Automated flow injection method for the high precision determination of drift tube ion mobility collision cross sections.

Authors:  Charles M Nichols; Jody C May; Stacy D Sherrod; John A McLean
Journal:  Analyst       Date:  2018-03-26       Impact factor: 4.616

Review 10.  Untargeted Metabolomics Strategies-Challenges and Emerging Directions.

Authors:  Alexandra C Schrimpe-Rutledge; Simona G Codreanu; Stacy D Sherrod; John A McLean
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-13       Impact factor: 3.109

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.